Soleus Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
BioAtla develops novel monoclonal antibody and cell-based therapeutics for cancer treatment using proprietary platforms including Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!).
BiotechHealthtechMedical DevicesSan Diego, US
Jay M. Short(Executive Officer, Director)Richard A. Waldron(Executive Officer)inCarolyn Short(Director)
Co-investorsKeshif VenturesPappas CapitalPfizer Venture InvestmentsHBM Healthcare InvestmentsPappas CapitalPfizer Ventures
SomaLogic develops proteomics tools that help researchers measure protein function and study human biology across a range of scientific applications.
BiotechDeep TechHealthtechBoulder, US
Larry Gold(Founder)inDaniel Muehl(Executive Officer)Byron Hewett(Executive Officer, Director)in
BoardCharles Lillis(Director)Youichi Yabuuchi(Director)Terry Randall(Director)
Co-investorsColorado BioScience AssociationForesite CapitalKhosla VenturesMaxqCasdin CapitalMagnetar Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






